In children with memory disorders, improvement occurred in 86.7% with Cortexin versus 63.3% with encephabol.
In plain wordsIn children with memory disorders, improvement occurred in 86.7% with Cortexin versus 63.3% with encephabol.
- Outcome
- IncreaseMemory disorder improvement
- Study
n = 60
- Comparator
- Encephabol
- Outcome group
- Cognition and memory · Nervous system and cognition
- Studied dose
- Dose not stated
Measurements
- Improvement
- 86.7%
- Cortexin
- Improvement
- 63.3%
- Encephabol
Source sentences
The higher cortexin efficacy (the improvement in 86.7% of cases) in comparison with encephabol (the improvement in 63.3% of cases) confirmed by the data of neuropsychological and neurophysiological research is established.
2 context sentences(design, population, supporting numbers)
Children, aged from 7 to 12 years, with memory disorders were treated with cortexin (30 patients) and encephabol (30 patients).
The comparative evaluation of efficacy and safety of these drugs was carried out.